ANL — Adlai Nortye Ltd. stock price, charts and financials

QT67Adlai Nortye Ltd.

Adlai Nortye Ltd. (NASDAQ: ANL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
13.00
+0.01+0.08%
OverviewShort InterestFilings
ANLQT67Adlai Nortye Ltd.·NASDAQ
13.00+0.08%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 20263Initial statement of beneficial ownership
Aug 03, 20266-KForeign issuer report
Jul 20, 2026424B7424B7
Jul 17, 20266-KForeign issuer report
Jul 15, 20263Initial statement of beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 01, 20263Initial statement of beneficial ownership
May 28, 20263Initial statement of beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 21, 20263Initial statement of beneficial ownership
May 20, 20263Initial statement of beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 20263/AInitial statement of beneficial ownership (amended)
May 08, 20263Initial statement of beneficial ownership
May 08, 20263/AInitial statement of beneficial ownership (amended)
Apr 29, 20263Initial statement of beneficial ownership
Apr 28, 2026EFFECTNotice of effectiveness
Apr 24, 2026F-3/AF-3/A
Apr 23, 2026F-3/AF-3/A
Apr 16, 20266-KForeign issuer report
Apr 10, 202620-FAnnual report (foreign issuers)
Apr 01, 20266-KForeign issuer report
Mar 10, 2026F-3F-3
Feb 12, 20266-KForeign issuer report
#1 / 25 of 90
Page
▼
/ 4